Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatrice Setnik

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Journal of Opioid Management|January 9, 2018
Letter to the Editor: Opioid Overdose Protection: An Inevitable Need to Address an Alarming EpidemicBeatrice Setnik
Pain Physician|July 26, 2011
Morphine sulfate and naltrexone hydrochloride extended-release capsules: naltrexone release, pharmacodynamics, and tolerabilityFranklin Johnson, Beatrice Setnik
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 20, 2004
Long-chain acyl-CoenzymeA synthetase-2 mRNA: increased cerebral cortex expression in an animal model of depressionBeatrice Setnik, José N Nobrega
Journal of Opioid Management|May 20, 2016
Establishing "abuse-deterrence equivalence" for generic abuse-deterrent opioid formulations: A proposed development frameworkBeatrice Setnik, Edward J Cone
Clinical Drug Investigation|April 30, 2017
Erratum to: Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: a randomized, doubleblind, placebo-controlled, crossover studyJoseph Stauffer, Beatrice Setnik, Marta Sokolowska
Pain Medicine (Malden, Mass.)|January 17, 2013
Response to letter by Dr. RuanBeatrice Setnik, Carl L Roland, Lynn Webster
Postgraduate Medicine|December 15, 2016
Assessing the impact of abuse-deterrent opioids (ADOs): identifying epidemiologic factors related to new entrants with low population exposureCarl L Roland, Beatrice Setnik, David A Brown
Current Medical Research and Opinion|December 24, 2015
Safety profile of extended-release morphine sulfate with sequestered naltrexone hydrochloride in older patients: pooled analysis of three clinical trialsBeatrice Setnik, Glenn C Pixton, Lynn R Webster
Journal of Clinical Pharmacology|July 23, 2016
Measurement of Drug Liking in Abuse Potential Studies: A Comparison of Unipolar and Bipolar Visual Analog ScalesBeatrice Setnik, Carl L Roland, Glenn Pixton, et al.
Human Psychopharmacology|June 10, 2014
Evaluation of the safety, pharmacodynamic, and pharmacokinetic effects following oral coadministration of immediate-release morphine with ethanol in healthy male participantsBeatrice Setnik, Marta Sokolowska, Franklin Johnson, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Journal of Opioid Management|January 9, 2018
Letter to the Editor: Opioid Overdose Protection: An Inevitable Need to Address an Alarming EpidemicBeatrice Setnik
Pain Physician|July 26, 2011
Morphine sulfate and naltrexone hydrochloride extended-release capsules: naltrexone release, pharmacodynamics, and tolerabilityFranklin Johnson, Beatrice Setnik
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 20, 2004
Long-chain acyl-CoenzymeA synthetase-2 mRNA: increased cerebral cortex expression in an animal model of depressionBeatrice Setnik, José N Nobrega
Journal of Opioid Management|May 20, 2016
Establishing "abuse-deterrence equivalence" for generic abuse-deterrent opioid formulations: A proposed development frameworkBeatrice Setnik, Edward J Cone
Clinical Drug Investigation|April 30, 2017
Erratum to: Subjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: a randomized, doubleblind, placebo-controlled, crossover studyJoseph Stauffer, Beatrice Setnik, Marta Sokolowska
Pain Medicine (Malden, Mass.)|January 17, 2013
Response to letter by Dr. RuanBeatrice Setnik, Carl L Roland, Lynn Webster
Postgraduate Medicine|December 15, 2016
Assessing the impact of abuse-deterrent opioids (ADOs): identifying epidemiologic factors related to new entrants with low population exposureCarl L Roland, Beatrice Setnik, David A Brown
Current Medical Research and Opinion|December 24, 2015
Safety profile of extended-release morphine sulfate with sequestered naltrexone hydrochloride in older patients: pooled analysis of three clinical trialsBeatrice Setnik, Glenn C Pixton, Lynn R Webster
Journal of Clinical Pharmacology|July 23, 2016
Measurement of Drug Liking in Abuse Potential Studies: A Comparison of Unipolar and Bipolar Visual Analog ScalesBeatrice Setnik, Carl L Roland, Glenn Pixton, et al.
Human Psychopharmacology|June 10, 2014
Evaluation of the safety, pharmacodynamic, and pharmacokinetic effects following oral coadministration of immediate-release morphine with ethanol in healthy male participantsBeatrice Setnik, Marta Sokolowska, Franklin Johnson, et al.
Pageof 6